| RS1439365177 |
KASH5
|
Health Risk |
Pathogenic |
Spermatogenic failure 88, Spermatogenic failure 88 |
| RS143936557 |
FANCD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, FANCD2-related disorder |
| RS1439380661 |
ESCO2
|
Health Risk |
Likely pathogenic |
— |
| RS143938822 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS143938897 |
TWNK
|
Health Risk |
Conflicting classifications of pathogenicity |
Thymoma, Thymoma |
| RS143938936 |
NAGLU
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis |
| RS143939123 |
DYSF
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Inborn genetic diseases |
| RS143939165 |
NOTCH3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS143939430 |
OTOF
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 9, Hearing loss |
| RS143939609 |
SMPD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Niemann-Pick disease, type B |
| RS1439403317 |
RAPSN
|
Health Risk |
Pathogenic |
Fetal akinesia deformation sequence 2, Fetal akinesia deformation sequence 2 |
| RS1439403341 |
H3-3A
|
Health Risk |
Likely pathogenic |
— |
| RS143941725 |
TSPEAR
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, TSPEAR-related disorder |
| RS143942248 |
CAPN3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2A, Autosomal recessive limb-girdle muscular dystrophy type 2A |
| RS143942705 |
GLI3
|
Health Risk |
Conflicting classifications of pathogenicity |
Pallister-Hall syndrome, Greig cephalopolysyndactyly syndrome |
| RS1439433665 |
MTRFR
|
Health Risk |
Likely pathogenic |
— |
| RS143943543 |
NCKAP1L
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 72 with autoinflammation, Cervical cancer |
| RS1439435536 |
GRIN2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 6 |
| RS143943560 |
FLNB
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS143944436 |
CUBN
|
Health Risk |
Pathogenic/Likely pathogenic |
Imerslund-Grasbeck syndrome, Imerslund-Grasbeck syndrome type 1 |
| RS1439452693 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1439464815 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS1439465660 |
POLR3A
|
Health Risk |
Pathogenic |
— |
| RS143946794 |
DUSP6
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypogonadotropic hypogonadism 19 with or without anosmia, Hypogonadotropic hypogonadism 19 with or without anosmia |
| RS143946953 |
CDK5RAP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 3, primary |
| RS1439469699 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Arrhythmogenic cardiomyopathy with wooly hair and keratoderma |
| RS1439470206 |
LRAT
|
Health Risk |
Pathogenic |
— |
| RS143947056 |
SGSH
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-III-A |
| RS1439475292 |
CARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined oxidative phosphorylation defect type 27, Combined oxidative phosphorylation defect type 27 |
| RS143947629 |
HR
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1439477100 |
PRKD1
|
Health Risk |
Likely pathogenic |
Congenital heart defects and ectodermal dysplasia, Congenital heart defects and ectodermal dysplasia |
| RS143947747 |
CC2D2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel syndrome, type 6 |
| RS143947828 |
MYH9
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 17, MYH9-related disorder |
| RS143948239 |
RELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS143948240 |
NBN
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Microcephaly |
| RS143948837 |
ACTA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Actin accumulation myopathy, Familial restrictive cardiomyopathy |
| RS143948954 |
RET
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, Renal hypodysplasia/aplasia 1 |
| RS143949083 |
FAT2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1439490873 |
A2ML1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS143950084 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS143950158 |
SPTB
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS143951267 |
RPS26
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 10, Diamond-Blackfan anemia |
| RS143951764 |
CSMD1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS143951897 |
CTR9
|
Health Risk |
Conflicting classifications of pathogenicity |
CTR9-related disorder, CTR9-related disorder |
| RS143952141 |
CHRM2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS143952512 |
MBD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 1 |
| RS143952576 |
AIRE
|
Health Risk |
Pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS143953116 |
SIK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 30 |
| RS1439533354 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Marfan syndrome |
| RS1439541639 |
ALMS1
|
Health Risk |
Pathogenic |
Alstrom syndrome, Alstrom syndrome |
| RS1439544901 |
HEXB
|
Health Risk |
Pathogenic |
Sandhoff disease, Sandhoff disease |
| RS143954665 |
PRPF8
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa 13, Retinitis pigmentosa 13 |
| RS143954739 |
ATP13A3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS143954787 |
TMEM70
|
Health Risk |
Conflicting classifications of pathogenicity |
Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2 |
| RS143954978 |
COMP
|
Health Risk |
Conflicting classifications of pathogenicity |
Connective tissue disorder, Connective tissue disorder |
| RS1439555171 |
TUBGCP4
|
Health Risk |
Pathogenic |
— |
| RS143955920 |
GRIN2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 6 |
| RS1439561211 |
MKS1
|
Health Risk |
Likely pathogenic |
Meckel syndrome, type 1 |
| RS143956557 |
FIG4
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 4 |
| RS143956614 |
SQSTM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Paget disease of bone 2, early-onset |
| RS143957561 |
AFG2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome, AFG2A-related disorder |
| RS143957574 |
POMK
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a |
| RS1439576531 |
PRPF31
|
Health Risk |
Pathogenic |
Retinitis pigmentosa, Retinitis pigmentosa |
| RS143957662 |
ASL
|
Health Risk |
Pathogenic/Likely pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS143957857 |
TUBGCP6
|
Health Risk |
Pathogenic |
— |
| RS143957922 |
PHYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Phytanic acid storage disease, Phytanic acid storage disease |
| RS1439582451 |
MFSD8
|
Health Risk |
Pathogenic/Likely pathogenic |
Neuronal ceroid lipofuscinosis 7, Neuronal ceroid lipofuscinosis 7 |
| RS143959492 |
IHH
|
Health Risk |
Conflicting classifications of pathogenicity |
IHH-related disorder, IHH-related disorder |
| RS143959504 |
FARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined oxidative phosphorylation defect type 14, Inborn genetic diseases |
| RS143960270 |
NPC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Niemann-Pick disease, type C2 |
| RS143960329 |
BBS12
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, Bardet-Biedl syndrome 12 |
| RS143960528 |
AKR1D1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, AKR1D1-related disorder |
| RS143960563 |
PGAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal recessive 42 |
| RS143961330 |
SLC25A20
|
Health Risk |
Conflicting classifications of pathogenicity |
Carnitine acylcarnitine translocase deficiency, Carnitine acylcarnitine translocase deficiency |
| RS143961472 |
GCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
GTP cyclohydrolase I deficiency, Dystonia 5 |
| RS143961484 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS1439617035 |
ACAT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of acetyl-CoA acetyltransferase, Deficiency of acetyl-CoA acetyltransferase |
| RS143962150 |
SGCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy, Autosomal recessive limb-girdle muscular dystrophy type 2D |
| RS1439623464 |
MYBPC3
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS143962510 |
CCM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cerebral cavernous malformation 2, Inborn genetic diseases |
| RS1439626978 |
COL1A1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1439633596 |
COL6A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Ullrich congenital muscular dystrophy 1A |
| RS143963391 |
BBS9
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome, BBS9-related disorder |
| RS143964295 |
COASY
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodegeneration with brain iron accumulation 6, COASY-related disorder |
| RS143965148 |
CHEK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS143965711 |
COL11A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 33, Autosomal dominant nonsyndromic hearing loss 33 |
| RS143966199 |
ADD3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1439667525 |
OTOGL
|
Health Risk |
Pathogenic |
— |
| RS143966918 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alagille syndrome due to a JAG1 point mutation, Tetralogy of Fallot |
| RS143967107 |
SLC6A5
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperekplexia 3, Inborn genetic diseases |
| RS1439688451 |
GRIN2A
|
Health Risk |
Pathogenic |
Self-limited epilepsy with centrotemporal spikes, Self-limited epilepsy with centrotemporal spikes |
| RS143969029 |
RAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe combined immunodeficiency, autosomal recessive |
| RS143969080 |
ATP1A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Alternating hemiplegia of childhood 1, Migraine |
| RS143971158 |
EVC
|
Health Risk |
Conflicting classifications of pathogenicity |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS1439712140 |
EVC
|
Health Risk |
Pathogenic |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS143971943 |
CSGALNACT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS143972053 |
KIF1C
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic ataxia 2, Hereditary spastic paraplegia |
| RS143972348 |
MYH9
|
Health Risk |
Conflicting classifications of pathogenicity |
MYH9-related disorder, Autosomal dominant nonsyndromic hearing loss 17 |
| RS143972531 |
PEX13
|
Health Risk |
Conflicting classifications of pathogenicity |
Peroxisome biogenesis disorder 11A (Zellweger), PEX13-related disorder |
| RS143972828 |
RELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial temporal lobe epilepsy 7, Norman-Roberts syndrome |